New journal features cutting-edge research across basic, clinical and translational immunology
HOBOKEN, NJ-Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence, today announced the launch of Advanced Immunology, a new open access journal designed to connect basic science and clinical discovery across the immune system.
This new title, now open for submissions, is part of the ongoing expansion of Wiley's Advanced Portfolio, reflecting Wiley's commitment to accelerating science that addresses humanity's most pressing challenges across a wide range of disciplines. Building on the recent launches of Advanced Oncology and Advanced Brain, the portfolio will continue to expand into areas of significant scientific importance.
The brand expansion-now a total of more than 30 Advanced titles and growing-demonstrates Wiley's drive to give researchers in every discipline access to the trusted, author-focused publishing experience that has distinguished the Advanced Portfolio for more than three decades.
Advanced Immunology is dedicated to publishing cutting-edge research across basic, clinical and translational immunology-from fundamental immune mechanisms to emerging technologies and clinical applications. It is designed to connect researchers across the full breadth of immunology, deepening understanding of the immune system in health and disease and translating discovery into meaningful impact on clinical practice and policy.
With its broad scope, the journal serves a wide-ranging research community, from basic immunologists to clinical scientists and medical researchers working at the intersection of immunology and related disciplines. It aspires to the high impact set by other Advanced Portfolio titles, underscoring the rigor researchers can expect from the journal.
Advanced Immunology is led by Editor-in-Chief Jay H. Bream, Ph.D. Bream brings extensive editorial experience to the role, having served as an editor for Frontiers in Immunology and an editorial board member for Genes and Immunity. As a professor of molecular microbiology and immunology at the Johns Hopkins Bloomberg School of Public Health for more than 20 years, Bream conducted research spanning cytokine biology, HIV immunology, vaccine science, and translational research, with more than 90 peer-reviewed publications.
"Immunology is advancing at a remarkable pace, reshaping our understanding of medicine," said Bream. "Advanced Immunology launches at the right moment, with a mission to showcase high-impact immunology research and bring together a global community of scientists around the questions that matter most. After more than 20 years running my own immunology research program, I cannot think of a more exciting time to champion this field."
Advanced Immunology is guided by an editorial advisory board of leading academics spanning the spectrum of immunology research and affiliated with institutions worldwide.
"The Advanced Portfolio exists to give researchers a publishing home that works the way science actually works-across disciplines, across communities, and across the full arc from discovery to real-world impact," said Allyn Molina, group vice president of publishing development at Wiley. "Immunology sits at the center of some of medicine's most urgent questions, and researchers deserve a dedicated space that reflects the breadth and growing influence on clinical practice. We are proud to launch Advanced Immunology as the latest expression of what this portfolio is designed to do."
Anchored by flagship interdisciplinary journal Advanced Science and the world-renowned Advanced Materials, Wiley's Advanced Portfolio has earned the trust of the global research community through a distinctive editorial approach built on close collaboration between authors and editors. It is designed to empower scientists and make publishing easier for researchers through a streamlined, collaborative approach.
